Part 1
Part 2
Part 3
Part 5
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Heparin API Market Size
M= millions and B=billions
This report is revolving around Heparin Active Pharmaceutical Ingredients (API). The global market for Heparin API was estimated to be worth US$ 2635.1 million in 2023 and is forecast to a readjusted size of US$ 6116.8 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030 Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc. In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply. Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%. The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue. Report Scope This report aims to provide a comprehensive presentation of the global market for Heparin API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin API by region & country, by Type, and by Application. The Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin API. Market Segmentation
Report Metric
Details
Report Title
Heparin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 6116.8 million
CAGR(2024-2030)
12.5%
Market Size Available for Years
2019-2030
Global Heparin API Companies Covered
Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, Dongying Tiandong Pharmaceutical, Opocrin, Hubei Enoray Biopharmaceutical, Yino Pharma, Cisen Pharmaceutical, Nanjing Xinbai Pharmaceutical, Sichuan Deebio Pharmaceutical
Global Heparin API Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Heparin API Market, Segment by Type
Heparin Sodium
Heparin Calcium
Global Heparin API Market, Segment by Application
UFH
LMWH
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Heparin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Heparin API in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion.
1 Market Overview
1.1 Heparin API Product Introduction
1.2 Global Heparin API Market Size Forecast
1.2.1 Global Heparin API Sales Value (2019-2030)
1.2.2 Global Heparin API Sales Volume (2019-2030)
1.2.3 Global Heparin API Sales Price (2019-2030)
1.3 Heparin API Market Trends & Drivers
1.3.1 Heparin API Industry Trends
1.3.2 Heparin API Market Drivers & Opportunity
1.3.3 Heparin API Market Challenges
1.3.4 Heparin API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Heparin API Players Revenue Ranking (2023)
2.2 Global Heparin API Revenue by Company (2019-2024)
2.3 Global Heparin API Players Sales Volume Ranking (2023)
2.4 Global Heparin API Sales Volume by Company Players (2019-2024)
2.5 Global Heparin API Average Price by Company (2019-2024)
2.6 Key Manufacturers Heparin API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Heparin API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Heparin API
2.9 Heparin API Market Competitive Analysis
2.9.1 Heparin API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Heparin API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Heparin Sodium
3.1.2 Heparin Calcium
3.2 Global Heparin API Sales Value by Type
3.2.1 Global Heparin API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Heparin API Sales Value, by Type (2019-2030)
3.2.3 Global Heparin API Sales Value, by Type (%) (2019-2030)
3.3 Global Heparin API Sales Volume by Type
3.3.1 Global Heparin API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Heparin API Sales Volume, by Type (2019-2030)
3.3.3 Global Heparin API Sales Volume, by Type (%) (2019-2030)
3.4 Global Heparin API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 UFH
4.1.2 LMWH
4.2 Global Heparin API Sales Value by Application
4.2.1 Global Heparin API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Heparin API Sales Value, by Application (2019-2030)
4.2.3 Global Heparin API Sales Value, by Application (%) (2019-2030)
4.3 Global Heparin API Sales Volume by Application
4.3.1 Global Heparin API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Heparin API Sales Volume, by Application (2019-2030)
4.3.3 Global Heparin API Sales Volume, by Application (%) (2019-2030)
4.4 Global Heparin API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Heparin API Sales Value by Region
5.1.1 Global Heparin API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Heparin API Sales Value by Region (2019-2024)
5.1.3 Global Heparin API Sales Value by Region (2025-2030)
5.1.4 Global Heparin API Sales Value by Region (%), (2019-2030)
5.2 Global Heparin API Sales Volume by Region
5.2.1 Global Heparin API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Heparin API Sales Volume by Region (2019-2024)
5.2.3 Global Heparin API Sales Volume by Region (2025-2030)
5.2.4 Global Heparin API Sales Volume by Region (%), (2019-2030)
5.3 Global Heparin API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Heparin API Sales Value, 2019-2030
5.4.2 North America Heparin API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Heparin API Sales Value, 2019-2030
5.5.2 Europe Heparin API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Heparin API Sales Value, 2019-2030
5.6.2 Asia Pacific Heparin API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Heparin API Sales Value, 2019-2030
5.7.2 South America Heparin API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Heparin API Sales Value, 2019-2030
5.8.2 Middle East & Africa Heparin API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Heparin API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Heparin API Sales Value
6.2.1 Key Countries/Regions Heparin API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Heparin API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Heparin API Sales Value, 2019-2030
6.3.2 United States Heparin API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Heparin API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Heparin API Sales Value, 2019-2030
6.4.2 Europe Heparin API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Heparin API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Heparin API Sales Value, 2019-2030
6.5.2 China Heparin API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Heparin API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Heparin API Sales Value, 2019-2030
6.6.2 Japan Heparin API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Heparin API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Heparin API Sales Value, 2019-2030
6.7.2 South Korea Heparin API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Heparin API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Heparin API Sales Value, 2019-2030
6.8.2 Southeast Asia Heparin API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Heparin API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Heparin API Sales Value, 2019-2030
6.9.2 India Heparin API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Heparin API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Shenzhen Hepalink Pharmaceutical
7.1.1 Shenzhen Hepalink Pharmaceutical Company Information
7.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
7.1.3 Shenzhen Hepalink Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Shenzhen Hepalink Pharmaceutical Heparin API Product Offerings
7.1.5 Shenzhen Hepalink Pharmaceutical Recent Development
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Company Information
7.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview
7.2.3 Yantai Dongcheng Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Yantai Dongcheng Pharmaceutical Heparin API Product Offerings
7.2.5 Yantai Dongcheng Pharmaceutical Recent Development
7.3 Nanjing King-friend Biochemical Pharmaceutical
7.3.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
7.3.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
7.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Product Offerings
7.3.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Heparin API Product Offerings
7.4.5 Pfizer Recent Development
7.5 Hebei Changshan Biochemical Pharmaceutical
7.5.1 Hebei Changshan Biochemical Pharmaceutical Company Information
7.5.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
7.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Product Offerings
7.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
7.6 Bioibérica
7.6.1 Bioibérica Company Information
7.6.2 Bioibérica Introduction and Business Overview
7.6.3 Bioibérica Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bioibérica Heparin API Product Offerings
7.6.5 Bioibérica Recent Development
7.7 Qingdao Jiulong Biopharmaceutical
7.7.1 Qingdao Jiulong Biopharmaceutical Company Information
7.7.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
7.7.3 Qingdao Jiulong Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Qingdao Jiulong Biopharmaceutical Heparin API Product Offerings
7.7.5 Qingdao Jiulong Biopharmaceutical Recent Development
7.8 Changzhou Qianhong Biopharma
7.8.1 Changzhou Qianhong Biopharma Company Information
7.8.2 Changzhou Qianhong Biopharma Introduction and Business Overview
7.8.3 Changzhou Qianhong Biopharma Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Changzhou Qianhong Biopharma Heparin API Product Offerings
7.8.5 Changzhou Qianhong Biopharma Recent Development
7.9 Dongying Tiandong Pharmaceutical
7.9.1 Dongying Tiandong Pharmaceutical Company Information
7.9.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview
7.9.3 Dongying Tiandong Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Dongying Tiandong Pharmaceutical Heparin API Product Offerings
7.9.5 Dongying Tiandong Pharmaceutical Recent Development
7.10 Opocrin
7.10.1 Opocrin Company Information
7.10.2 Opocrin Introduction and Business Overview
7.10.3 Opocrin Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Opocrin Heparin API Product Offerings
7.10.5 Opocrin Recent Development
7.11 Hubei Enoray Biopharmaceutical
7.11.1 Hubei Enoray Biopharmaceutical Company Information
7.11.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview
7.11.3 Hubei Enoray Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Hubei Enoray Biopharmaceutical Heparin API Product Offerings
7.11.5 Hubei Enoray Biopharmaceutical Recent Development
7.12 Yino Pharma
7.12.1 Yino Pharma Company Information
7.12.2 Yino Pharma Introduction and Business Overview
7.12.3 Yino Pharma Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Yino Pharma Heparin API Product Offerings
7.12.5 Yino Pharma Recent Development
7.13 Cisen Pharmaceutical
7.13.1 Cisen Pharmaceutical Company Information
7.13.2 Cisen Pharmaceutical Introduction and Business Overview
7.13.3 Cisen Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Cisen Pharmaceutical Heparin API Product Offerings
7.13.5 Cisen Pharmaceutical Recent Development
7.14 Nanjing Xinbai Pharmaceutical
7.14.1 Nanjing Xinbai Pharmaceutical Company Information
7.14.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview
7.14.3 Nanjing Xinbai Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Nanjing Xinbai Pharmaceutical Heparin API Product Offerings
7.14.5 Nanjing Xinbai Pharmaceutical Recent Development
7.15 Sichuan Deebio Pharmaceutical
7.15.1 Sichuan Deebio Pharmaceutical Company Information
7.15.2 Sichuan Deebio Pharmaceutical Introduction and Business Overview
7.15.3 Sichuan Deebio Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Sichuan Deebio Pharmaceutical Heparin API Product Offerings
7.15.5 Sichuan Deebio Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Heparin API Industrial Chain
8.2 Heparin API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Heparin API Sales Model
8.5.2 Sales Channel
8.5.3 Heparin API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Heparin API Market Trends Table 2. Heparin API Market Drivers & Opportunity Table 3. Heparin API Market Challenges Table 4. Heparin API Market Restraints Table 5. Global Heparin API Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Heparin API Revenue Market Share by Company (2019-2024) Table 7. Global Heparin API Sales Volume by Company (2019-2024) & (Billion Units) Table 8. Global Heparin API Sales Volume Market Share by Company (2019-2024) Table 9. Global Market Heparin API Price by Company (2019-2024) & (USD/Billion Units) Table 10. Key Manufacturers Heparin API Manufacturing Base Distribution and Headquarters Table 11. Key Manufacturers Heparin API Product Type Table 12. Key Manufacturers Time to Begin Mass Production of Heparin API Table 13. Global Heparin API Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin API as of 2023) Table 15. Mergers & Acquisitions, Expansion Plans Table 16. Global Heparin API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 17. Global Heparin API Sales Value by Type (2019-2024) & (US$ Million) Table 18. Global Heparin API Sales Value by Type (2025-2030) & (US$ Million) Table 19. Global Heparin API Sales Market Share in Value by Type (2019-2024) & (%) Table 20. Global Heparin API Sales Market Share in Value by Type (2025-2030) & (%) Table 21. Global Heparin API Sales Volume by Type: 2019 VS 2023 VS 2030 (Billion Units) Table 22. Global Heparin API Sales Volume by Type (2019-2024) & (Billion Units) Table 23. Global Heparin API Sales Volume by Type (2025-2030) & (Billion Units) Table 24. Global Heparin API Sales Market Share in Volume by Type (2019-2024) & (%) Table 25. Global Heparin API Sales Market Share in Volume by Type (2025-2030) & (%) Table 26. Global Heparin API Price by Type (2019-2024) & (USD/Billion Units) Table 27. Global Heparin API Price by Type (2025-2030) & (USD/Billion Units) Table 28. Global Heparin API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 29. Global Heparin API Sales Value by Application (2019-2024) & (US$ Million) Table 30. Global Heparin API Sales Value by Application (2025-2030) & (US$ Million) Table 31. Global Heparin API Sales Market Share in Value by Application (2019-2024) & (%) Table 32. Global Heparin API Sales Market Share in Value by Application (2025-2030) & (%) Table 33. Global Heparin API Sales Volume by Application: 2019 VS 2023 VS 2030 (Billion Units) Table 34. Global Heparin API Sales Volume by Application (2019-2024) & (Billion Units) Table 35. Global Heparin API Sales Volume by Application (2025-2030) & (Billion Units) Table 36. Global Heparin API Sales Market Share in Volume by Application (2019-2024) & (%) Table 37. Global Heparin API Sales Market Share in Volume by Application (2025-2030) & (%) Table 38. Global Heparin API Price by Application (2019-2024) & (USD/Billion Units) Table 39. Global Heparin API Price by Application (2025-2030) & (USD/Billion Units) Table 40. Global Heparin API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 41. Global Heparin API Sales Value by Region (2019-2024) & (US$ Million) Table 42. Global Heparin API Sales Value by Region (2025-2030) & (US$ Million) Table 43. Global Heparin API Sales Value by Region (2019-2024) & (%) Table 44. Global Heparin API Sales Value by Region (2025-2030) & (%) Table 45. Global Heparin API Sales Volume by Region (Billion Units): 2019 VS 2023 VS 2030 Table 46. Global Heparin API Sales Volume by Region (2019-2024) & (Billion Units) Table 47. Global Heparin API Sales Volume by Region (2025-2030) & (Billion Units) Table 48. Global Heparin API Sales Volume by Region (2019-2024) & (%) Table 49. Global Heparin API Sales Volume by Region (2025-2030) & (%) Table 50. Global Heparin API Average Price by Region (2019-2024) & (USD/Billion Units) Table 51. Global Heparin API Average Price by Region (2025-2030) & (USD/Billion Units) Table 52. Key Countries/Regions Heparin API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 53. Key Countries/Regions Heparin API Sales Value, (2019-2024) & (US$ Million) Table 54. Key Countries/Regions Heparin API Sales Value, (2025-2030) & (US$ Million) Table 55. Key Countries/Regions Heparin API Sales Volume, (2019-2024) & (Billion Units) Table 56. Key Countries/Regions Heparin API Sales Volume, (2025-2030) & (Billion Units) Table 57. Shenzhen Hepalink Pharmaceutical Company Information Table 58. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview Table 59. Shenzhen Hepalink Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 60. Shenzhen Hepalink Pharmaceutical Heparin API Product Offerings Table 61. Shenzhen Hepalink Pharmaceutical Recent Development Table 62. Yantai Dongcheng Pharmaceutical Company Information Table 63. Yantai Dongcheng Pharmaceutical Introduction and Business Overview Table 64. Yantai Dongcheng Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 65. Yantai Dongcheng Pharmaceutical Heparin API Product Offerings Table 66. Yantai Dongcheng Pharmaceutical Recent Development Table 67. Nanjing King-friend Biochemical Pharmaceutical Company Information Table 68. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview Table 69. Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 70. Nanjing King-friend Biochemical Pharmaceutical Heparin API Product Offerings Table 71. Nanjing King-friend Biochemical Pharmaceutical Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Introduction and Business Overview Table 74. Pfizer Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 75. Pfizer Heparin API Product Offerings Table 76. Pfizer Recent Development Table 77. Hebei Changshan Biochemical Pharmaceutical Company Information Table 78. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview Table 79. Hebei Changshan Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 80. Hebei Changshan Biochemical Pharmaceutical Heparin API Product Offerings Table 81. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 82. Bioibérica Company Information Table 83. Bioibérica Introduction and Business Overview Table 84. Bioibérica Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 85. Bioibérica Heparin API Product Offerings Table 86. Bioibérica Recent Development Table 87. Qingdao Jiulong Biopharmaceutical Company Information Table 88. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview Table 89. Qingdao Jiulong Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 90. Qingdao Jiulong Biopharmaceutical Heparin API Product Offerings Table 91. Qingdao Jiulong Biopharmaceutical Recent Development Table 92. Changzhou Qianhong Biopharma Company Information Table 93. Changzhou Qianhong Biopharma Introduction and Business Overview Table 94. Changzhou Qianhong Biopharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 95. Changzhou Qianhong Biopharma Heparin API Product Offerings Table 96. Changzhou Qianhong Biopharma Recent Development Table 97. Dongying Tiandong Pharmaceutical Company Information Table 98. Dongying Tiandong Pharmaceutical Introduction and Business Overview Table 99. Dongying Tiandong Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 100. Dongying Tiandong Pharmaceutical Heparin API Product Offerings Table 101. Dongying Tiandong Pharmaceutical Recent Development Table 102. Opocrin Company Information Table 103. Opocrin Introduction and Business Overview Table 104. Opocrin Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 105. Opocrin Heparin API Product Offerings Table 106. Opocrin Recent Development Table 107. Hubei Enoray Biopharmaceutical Company Information Table 108. Hubei Enoray Biopharmaceutical Introduction and Business Overview Table 109. Hubei Enoray Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 110. Hubei Enoray Biopharmaceutical Heparin API Product Offerings Table 111. Hubei Enoray Biopharmaceutical Recent Development Table 112. Yino Pharma Company Information Table 113. Yino Pharma Introduction and Business Overview Table 114. Yino Pharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 115. Yino Pharma Heparin API Product Offerings Table 116. Yino Pharma Recent Development Table 117. Cisen Pharmaceutical Company Information Table 118. Cisen Pharmaceutical Introduction and Business Overview Table 119. Cisen Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 120. Cisen Pharmaceutical Heparin API Product Offerings Table 121. Cisen Pharmaceutical Recent Development Table 122. Nanjing Xinbai Pharmaceutical Company Information Table 123. Nanjing Xinbai Pharmaceutical Introduction and Business Overview Table 124. Nanjing Xinbai Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 125. Nanjing Xinbai Pharmaceutical Heparin API Product Offerings Table 126. Nanjing Xinbai Pharmaceutical Recent Development Table 127. Sichuan Deebio Pharmaceutical Company Information Table 128. Sichuan Deebio Pharmaceutical Introduction and Business Overview Table 129. Sichuan Deebio Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (USD/Billion Units) and Gross Margin (2019-2024) Table 130. Sichuan Deebio Pharmaceutical Heparin API Product Offerings Table 131. Sichuan Deebio Pharmaceutical Recent Development Table 132. Key Raw Materials Lists Table 133. Raw Materials Key Suppliers Lists Table 134. Heparin API Downstream Customers Table 135. Heparin API Distributors List Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Heparin API Product Picture Figure 2. Global Heparin API Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Heparin API Sales Value (2019-2030) & (US$ Million) Figure 4. Global Heparin API Sales Volume (2019-2030) & (Billion Units) Figure 5. Global Heparin API Sales Price (2019-2030) & (USD/Billion Units) Figure 6. Heparin API Report Years Considered Figure 7. Global Heparin API Players Revenue Ranking (2023) & (US$ Million) Figure 8. Global Heparin API Players Sales Volume Ranking (2023) & (Billion Units) Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin API Revenue in 2023 Figure 10. Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 11. Heparin Sodium Picture Figure 12. Heparin Calcium Picture Figure 13. Global Heparin API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 14. Global Heparin API Sales Value Market Share by Type, 2023 & 2030 Figure 15. Global Heparin API Sales Volume by Type (2019 VS 2023 VS 2030) & (Billion Units) Figure 16. Global Heparin API Sales Volume Market Share by Type, 2023 & 2030 Figure 17. Global Heparin API Price by Type (2019-2030) & (USD/Billion Units) Figure 18. Product Picture of UFH Figure 19. Product Picture of LMWH Figure 20. Global Heparin API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 21. Global Heparin API Sales Value Market Share by Application, 2023 & 2030 Figure 22. Global Heparin API Sales Volume by Application (2019 VS 2023 VS 2030) & (Billion Units) Figure 23. Global Heparin API Sales Volume Market Share by Application, 2023 & 2030 Figure 24. Global Heparin API Price by Application (2019-2030) & (USD/Billion Units) Figure 25. North America Heparin API Sales Value (2019-2030) & (US$ Million) Figure 26. North America Heparin API Sales Value by Country (%), 2023 VS 2030 Figure 27. Europe Heparin API Sales Value (2019-2030) & (US$ Million) Figure 28. Europe Heparin API Sales Value by Country (%), 2023 VS 2030 Figure 29. Asia Pacific Heparin API Sales Value (2019-2030) & (US$ Million) Figure 30. Asia Pacific Heparin API Sales Value by Country (%), 2023 VS 2030 Figure 31. South America Heparin API Sales Value (2019-2030) & (US$ Million) Figure 32. South America Heparin API Sales Value by Country (%), 2023 VS 2030 Figure 33. Middle East & Africa Heparin API Sales Value (2019-2030) & (US$ Million) Figure 34. Middle East & Africa Heparin API Sales Value by Country (%), 2023 VS 2030 Figure 35. Key Countries/Regions Heparin API Sales Value (%), (2019-2030) Figure 36. Key Countries/Regions Heparin API Sales Volume (%), (2019-2030) Figure 37. United States Heparin API Sales Value, (2019-2030) & (US$ Million) Figure 38. United States Heparin API Sales Value by Type (%), 2023 VS 2030 Figure 39. United States Heparin API Sales Value by Application (%), 2023 VS 2030 Figure 40. Europe Heparin API Sales Value, (2019-2030) & (US$ Million) Figure 41. Europe Heparin API Sales Value by Type (%), 2023 VS 2030 Figure 42. Europe Heparin API Sales Value by Application (%), 2023 VS 2030 Figure 43. China Heparin API Sales Value, (2019-2030) & (US$ Million) Figure 44. China Heparin API Sales Value by Type (%), 2023 VS 2030 Figure 45. China Heparin API Sales Value by Application (%), 2023 VS 2030 Figure 46. Japan Heparin API Sales Value, (2019-2030) & (US$ Million) Figure 47. Japan Heparin API Sales Value by Type (%), 2023 VS 2030 Figure 48. Japan Heparin API Sales Value by Application (%), 2023 VS 2030 Figure 49. South Korea Heparin API Sales Value, (2019-2030) & (US$ Million) Figure 50. South Korea Heparin API Sales Value by Type (%), 2023 VS 2030 Figure 51. South Korea Heparin API Sales Value by Application (%), 2023 VS 2030 Figure 52. Southeast Asia Heparin API Sales Value, (2019-2030) & (US$ Million) Figure 53. Southeast Asia Heparin API Sales Value by Type (%), 2023 VS 2030 Figure 54. Southeast Asia Heparin API Sales Value by Application (%), 2023 VS 2030 Figure 55. India Heparin API Sales Value, (2019-2030) & (US$ Million) Figure 56. India Heparin API Sales Value by Type (%), 2023 VS 2030 Figure 57. India Heparin API Sales Value by Application (%), 2023 VS 2030 Figure 58. Heparin API Industrial Chain Figure 59. Heparin API Manufacturing Cost Structure Figure 60. Channels of Distribution (Direct Sales, and Distribution) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
This report is revolving around Heparin Active Pharmaceutical Ingredients (API). The global market for Heparin API was estimated to be worth US$ 2635.1 million in 2023 and is forecast to a readjusted size of US$ 6116.8 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030 Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc. In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply. Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%. The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue. Report Scope This report aims to provide a comprehensive presentation of the global market for Heparin API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin API by region & country, by Type, and by Application. The Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin API. Market Segmentation
Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Heparin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Heparin API in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion.
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now